ArticleCancer chemotherapy and pharmacology2019

A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer.

Cody J Peer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.